<SEC-DOCUMENT>0001437749-25-008989-index.html : 20250324
<SEC-HEADER>0001437749-25-008989.hdr.sgml : 20250324
<ACCEPTANCE-DATETIME>20250324165019
ACCESSION NUMBER:		0001437749-25-008989
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20250324
DATE AS OF CHANGE:		20250324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Clene Inc.
		CENTRAL INDEX KEY:			0001822791
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				852828339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286058
		FILM NUMBER:		25764802

	BUSINESS ADDRESS:	
		STREET 1:		6550 SOUTH MILLROCK DRIVE, SUITE G50
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84121
		BUSINESS PHONE:		801-676-9695

	MAIL ADDRESS:	
		STREET 1:		6550 SOUTH MILLROCK DRIVE, SUITE G50
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Chelsea Worldwide Inc.
		DATE OF NAME CHANGE:	20200827
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>clnn20240815_s3.htm
<DESCRIPTION>FORM S-3
<TEXT>
Document 1 - file: clnn20240815_s3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ex_715566.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: ex_715566.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>3 <FILENAME>ex_715567.htm <DESCRIPTION>EXHIBIT 23.2 <TEXT> Document 3 - file: ex_715567.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>ex_717302.htm <DESCRIPTION>EXHIBIT 107 <TEXT> Document 4 - file: ex_717302.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>clenelogo11percent.jpg <TEXT> Document 5 - file: clenelogo11percent.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>hklogo35px.jpg <TEXT> Document 6 - file: hklogo35px.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>pipelinejan2025_22pct.jpg <TEXT> Document 7 - file: pipelinejan2025_22pct.jpg
</DOCUMENT> </SEC-DOCUMENT>